Catalyst Wire Dossier Catalyst Wire Dossier

AR882

· Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for AR882, covering 2020-11-19 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients [Phase 2]

See pricing